Ganciclovir Capsules bulk supplier for pharma manufacturers

Ganciclovir Capsules 250 mg Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 250 mg

Reference Brands: Cytovene (USA/EU)

Ganciclovir 250 mg oral capsules, an older CMV maintenance and prophylaxis form now largely replaced by valganciclovir, for importers and hospital pharmacies in markets where it remains registered.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Ganciclovir Capsules? List it or send an offer →

Product Description:

Ganciclovir is a guanine nucleoside analogue active against cytomegalovirus (CMV) and other herpesviruses. A viral kinase adds the first phosphate in infected cells, cellular enzymes complete the triphosphate, and this blocks viral DNA polymerase. This page covers 250 mg oral capsules. Oral ganciclovir is poorly absorbed, needs large doses several times a day and was never used to start treatment of active disease. Valganciclovir, an oral prodrug giving far higher levels, has largely replaced the capsules, which many countries no longer market.

Where still registered, the capsules have served as maintenance for CMV retinitis in advanced HIV after intravenous induction, and as CMV prophylaxis in transplant recipients. They are taken with food to improve absorption. Bone marrow suppression is the main hazard, so blood counts are monitored closely, and doses are cut in renal impairment. Ganciclovir is carcinogenic and teratogenic in animals, so both sexes need contraception. Zidovudine adds myelotoxicity, and imipenem-cilastatin has been linked to seizures.

Sourcing notes. First confirm the capsules hold a current registration, since many regulators now list only valganciclovir and intravenous ganciclovir. Ganciclovir is a hazardous drug: capsules are not opened or crushed, and repackers follow cytotoxic handling rules. Ask for the CTD or ACTD dossier with bioequivalence data, a batch CoA, the GMP certificate and a CoPP. Packs should keep out moisture at room temperature, with zone IVb stability for hot, humid destinations. State pack size, labelling language and annual volume.

Ganciclovir Capsules — third party manufacturing & bulk supply

Ganciclovir Capsules 250 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Ganciclovir Capsules is supplied as Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Ganciclovir Capsules listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Ganciclovir Capsules →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Ganciclovir is used to treat and prevent cytomegalovirus (CMV) infections, particularly in immunocompromised patients such as those with HIV/AIDS or organ transplant recipients. It helps reduce viral replication and control the severity of CMV-related complications.

Ganciclovir is made from the active ingredient ganciclovir, which is a synthetic nucleoside analogue of guanine. It works by inhibiting viral DNA polymerase, preventing the virus from multiplying.

Common trade names for ganciclovir include Cytovene and Cymevene, depending on the region and formulation.

Cytovene and Cymevene were originally manufactured by Roche. Many other pharmaceutical companies now produce generic ganciclovir in injectable and oral forms.

The generic name is ganciclovir.

Brand names include Cytovene and Cymevene, in addition to various generic brands supplied by multiple manufacturers worldwide.

Ganciclovir is manufactured by several approved pharmaceutical companies in regions including India, Europe, and the United States, depending on the brand or generic version.